NORM LEHMAN to Aurora Kinase A
This is a "connection" page, showing publications NORM LEHMAN has written about Aurora Kinase A.
Connection Strength
2.741
-
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo. Cancer Chemother Pharmacol. 2023 02; 91(2):191-201.
Score: 0.801
-
Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal M?llerian epithelium and benign, borderline and malignant serous ovarian neoplasms. Diagn Pathol. 2021 Oct 27; 16(1):98.
Score: 0.734
-
The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells. J Neurooncol. 2018 May; 137(3):481-492.
Score: 0.567
-
Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014 Oct 01; 74(19):5364-70.
Score: 0.445
-
Differential expression of aurora-A kinase in T-cell lymphomas. Mod Pathol. 2013 May; 26(5):640-7.
Score: 0.100
-
Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle. 2012 Feb 01; 11(3):489-502.
Score: 0.093